Category: Cardiac Rhythm Management
The FDA warns again of issues that may prevent Philips' HeartStart automated defibrillators from delivering emergency therapy.
MASSDEVICE ON CALL — Medtech giant Philips Healthcare (NYSE:PHG) got renewed attention for its troubled HeartStart automated external defibrillators after the FDA this week issued a new warning letter over potentially faulty electrical components.
Sorin wins CE Mark approval in the European Union for its Kora 100 MRI-compatible pacemaker.
Sorin Group (BIT:SRN) said it won CE Mark approval in the European Union for its Kora 100 DR and SR pacemakers.
A federal judge shoots down bids by Philips and Zoll to dismiss a patent infringement case over automated external defibrillator technology.
AtriCure says the FDA granted an investigational device exemption for a clinical trial of its AtriClip left atrial appendage exclusion device to gauge its utility in preventing stroke in patients with atrial fibrillation.
AtriCure (NSDQ:ATRC) said today that the FDA approved the launch of a clinical trial to examine whether its AtriClip device can be used to prevent strokes in patients with atrial fibrillation.
Shares of Boston Scientific gain after Medtronic's fiscal 2nd-quarter results reveal higher-than-expected sales for its implantable cardioverter defibrillators.
Medtronic's enhanced pacemakers may help delay the onset of permanent atrial fibrillation and keep patients out of the emergency room, researchers say.
The justices on the U.S. Supreme Court seem to favor Medtronic's arguments in its patent battle with Boston Scientific during oral arguments this week.